Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, announced that its wholly owned subsidiary, Algernon NeuroScience (AGN Neuro), has appointed Validcare as ...

AGN Neuro is also pleased to announce that as part of being appointed the CRO, Validcare has agreed to invest US $170K in exchange for equity issued by AGN Neuro. The investment in AGN Neuro will be ...

Piedmont had record quarterly shipments of ~55,700 dmt of spodumene concentrate in Q4'24, modestly exceeding guidance NAL ...

Piedmont Lithium Inc. ("Piedmont," the "Company," "we," "our," or "us") (Nasdaq: PLL; ASX: PLL), a leading North American ...

Quarterly production of 3.6M wmt, sales of 3.3M dmt, revenue of $363M and EBITDA of $88M1 DRPF project advancing on budget and as scheduled for commissioning in 2025, including an additional $69M ...

Elon Musk was among the many Donald Trump supporters and appointees present in Washington D.C. for Monday’s inauguration ceremony, and he even gave a speech during the rally event later that ...

JENNER FURST: So there's two narratives. There's the narrative that we've been given for the last four years, and there's the actual fact pattern and what is the closest to the truth that we ...